<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29726898</article-id>
<article-id pub-id-type="pmc">6061867</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddy167</article-id>
<article-id pub-id-type="publisher-id">ddy167</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Invited Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Enhancers: bridging the gap between gene control and human disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Karnuta</surname>
<given-names>Jaret M</given-names>
</name>
<xref ref-type="aff" rid="ddy167-aff1">1</xref>
<xref ref-type="aff" rid="ddy167-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scacheri</surname>
<given-names>Peter C</given-names>
</name>
<xref ref-type="aff" rid="ddy167-aff1">1</xref>
<xref ref-type="corresp" rid="ddy167-cor1"></xref>
<!--<email>pxs183@case.edu</email>-->
</contrib>
</contrib-group>
<aff id="ddy167-aff1"><label>1</label>Department of Genetics and Genome Sciences, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA</aff>
<aff id="ddy167-aff2"><label>2</label>Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA</aff>
<author-notes>
<corresp id="ddy167-cor1">To whom correspondence should be addressed. Tel: (216) 368-3458; Fax: (216) 368-3432; Email: <email>pxs183@case.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date iso-8601-date="2018-05-02" pub-type="epub">
<day>02</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>27</volume>
<issue>R2</issue>
<fpage>R219</fpage>
<lpage>R227</lpage>
<history>
<date date-type="received">
<day>02</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>02</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>5</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Â© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="oup-standard" xlink:href="https://academic.oup.com/journals/pages/about_us/legal/notices">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/about_us/legal/notices">https://academic.oup.com/journals/pages/about_us/legal/notices</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="ddy167.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Enhancers are a class of regulatory elements essential for precise spatio-temporal control of gene expression during development and in terminally differentiated cells. This review highlights signature features of enhancer elements as well as new advances that provide mechanistic insights into enhancer-mediated gene control in the context of three-dimensional chromatin. We detail the various ways in which non-coding mutations can instigate aberrant gene control and cause a variety of Mendelian disorders, common diseases and cancer.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>R01DA043980</award-id>
<award-id>R01CA193677</award-id>
<award-id>R01CA204279</award-id>
<award-id>R01CA143237</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="9"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>